FHIR IG analytics| Package | de.medizininformatikinitiative.kerndatensatz.onkologie |
| Resource Type | RequestGroup |
| Id | RequestGroup-mii-exa-onko-folfox-requestgroup-modification.json |
| FHIR Version | R4 |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
English
Generated Narrative: RequestGroup mii-exa-onko-folfox-requestgroup-modification
Profile: MII PR Onkologie Therapieempfehlung Kombinationstherapie version: 2027.0.0-ballot.1
status: Active
intent: Proposal
code: Chemotherapie
subject: Martin Beispiel Male, DoB: 1958-11-03
authoredOn: 2024-03-05
reasonReference: Condition Bösartige Neubildung: Colon ascendens
action
title: FOLFOX4 Protocol
description: FOLFOX4 chemotherapy protocol: Fluorouracil + Folinsäure + Oxaliplatin, 12 cycles planned
code: FOLFOX4
Actions
Title Description Resource Fluorouracil (5-FU) 5-Fluorouracil - pyrimidine analog MedicationRequest: status = completed; intent = proposal; medication[x] = Fluorouracil; authoredOn = 2024-03-05; note = Completed as planned for all 12 cycles Folinsäure (Leucovorin) Folinic acid - enhances 5-FU efficacy MedicationRequest: status = completed; intent = proposal; medication[x] = Calciumfolinat; authoredOn = 2024-03-05; note = Completed as planned for all 12 cycles Oxaliplatin Platinum-based chemotherapy agent MedicationRequest: status = stopped; statusReason = Adverse reaction (disorder); intent = proposal; medication[x] = Oxaliplatin; authoredOn = 2024-03-05; note = Administered for cycles 1-6 only. Stopped due to cumulative neurotoxicity.
German
Generated Narrative: RequestGroup mii-exa-onko-folfox-requestgroup-modification
Profile: MII PR Onkologie Therapieempfehlung Kombinationstherapie version: 2027.0.0-ballot.1
status: Active
intent: Proposal
code: Chemotherapie
subject: Martin Beispiel Male, DoB: 1958-11-03
authoredOn: 2024-03-05
reasonReference: Condition Bösartige Neubildung: Colon ascendens
action
title: FOLFOX4 Protocol
description: FOLFOX4 chemotherapy protocol: Fluorouracil + Folinsäure + Oxaliplatin, 12 cycles planned
code: FOLFOX4
Actions
Title Description Resource Fluorouracil (5-FU) 5-Fluorouracil - pyrimidine analog MedicationRequest: status = completed; intent = proposal; medication[x] = Fluorouracil; authoredOn = 2024-03-05; note = Completed as planned for all 12 cycles Folinsäure (Leucovorin) Folinic acid - enhances 5-FU efficacy MedicationRequest: status = completed; intent = proposal; medication[x] = Calciumfolinat; authoredOn = 2024-03-05; note = Completed as planned for all 12 cycles Oxaliplatin Platinum-based chemotherapy agent MedicationRequest: status = stopped; statusReason = Adverse reaction (disorder); intent = proposal; medication[x] = Oxaliplatin; authoredOn = 2024-03-05; note = Administered for cycles 1-6 only. Stopped due to cumulative neurotoxicity.
FHIR
FHIRsmith{
"resourceType": "RequestGroup",
"id": "mii-exa-onko-folfox-requestgroup-modification",
"meta": {
"profile": [
"https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-therapieempfehlung-kombinationstherapie|2027.0.0-ballot.1"
]
},
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"status": "active",
"intent": "proposal",
"code": {
"coding": [
{
"system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-typ",
"code": "CH",
"display": "Chemotherapie"
}
],
"text": "Chemotherapie"
},
"subject": {
"reference": "Patient/example-modification"
},
"authoredOn": "2024-03-05",
"reasonReference": [
{
"reference": "Condition/mii-exa-onko-ascending-colon-cancer-diagnosis"
}
],
"action": [
{
"title": "FOLFOX4 Protocol",
"description": "FOLFOX4 chemotherapy protocol: Fluorouracil + Folinsäure + Oxaliplatin, 12 cycles planned",
"code": [
{
"coding": [
{
"system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-systemische-therapie-protokolle",
"code": "FOLFOX4",
"display": "FOLFOX4"
}
]
}
],
"action": [
{
"title": "Fluorouracil (5-FU)",
"description": "5-Fluorouracil - pyrimidine analog",
"resource": {
"reference": "MedicationRequest/mii-exa-onko-modification-5fu-request"
}
},
{
"title": "Folinsäure (Leucovorin)",
"description": "Folinic acid - enhances 5-FU efficacy",
"resource": {
"reference": "MedicationRequest/mii-exa-onko-modification-leucovorin-request"
}
},
{
"title": "Oxaliplatin",
"description": "Platinum-based chemotherapy agent",
"resource": {
"reference": "MedicationRequest/mii-exa-onko-modification-oxaliplatin-request"
}
}
]
}
]
}